Skip Navigation

JNCI Journal of the National Cancer Institute 1992 84(21):1633-1638; doi:10.1093/jnci/84.21.1633
© 1992 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kibbey, M. C.
Right arrow Articles by Kleinman, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kibbey, M. C.
Right arrow Articles by Kleinman, H. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 84, No. 21, 1633-1638, November 4, 1992
© 1992 Oxford University Press

Role of the SIKVAV Site of Laminin in Promotion of Angiogenesis and Tumor Growth: An In Vivo Matrigel Model

Maura C. Kibbey*, Derrick S. Grant, Hynda K. Kleinman

Laboratory of Developmental Biology, National Institute of Dental Research Bethesda, Md.

*Correspondence to:Maura C. Kibbey, Ph.D., National Institutes of Health, Bldg. 30, Rm. 402, Bethesda, MD 20892.

Background: Angiogenesis (vascularization) has a critical role in tumor growth and metastasis, and peptides containing the SIKVAV amino acid sequence (Ser-Ile-Lys-Val-Ala-Val) have been shown to stimulate many angiogenic activities in vitro. The use of model systems to identify agents that stimulate or inhibit angiogenesis may lead to the development of new antitumor strategies. Purpose: Our purpose was to use an in vivo murine model system to study the angiogenic activity of a synthetic peptide derived from the laminin A protein chain and containing the SIKVAV amino acid sequence. We also examined the ability of the peptide to enhance tumor growth in vivo. Methods: The SIKVAV-containing peptide was mixed with Matrigel, a reconstituted basement membrane extract used to assay stimulation of angiogenesis. The mixture was subcutaneously injected into C57BL/6 mice. At various times after injection, the Matrigel plug was excised, and angiogenic activity was assessed by histologic examination and immunohistochemical staining with an antibody to the von Wille-brand factor (vWF), an endothelium-specific antigen. In other experiments, the mixture of peptide and Matrigel was co-injected with B16F10 murine melanoma cells into C57BL/6 mice, and the resultant tumors were assessed for size and vascularization.

Results: When co-injected with Matrigel at doses as low as 10 µg, the SIKVAV-containing peptide stimulated angiogenesis fourfold greater than that seen in controls, and maximum angiogenic activity was observed 2 weeks after injection. This peptide was angiogenic in a dose-dependent manner up to a 100-µg dose. When co-injected with Matrigel and B16F10 melanoma cells, the peptide enhanced tumor growth by approximately 2.5-fold, and tumor vascularization was significantly increased (P =.027) over that observed after injection with melanoma cells and Matrigel alone. Conclusions: These data demonstrate that the laminin-derived SIKVAV-containing peptide is angiogenic in a new in vivo model system and can enhance tumor vascularization and growth. [J Natl Cancer Inst 84: 1633–1638, 1992]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
V. M. Freitas, V. F. Vilas-Boas, D. C. Pimenta, V. Loureiro, M. A. Juliano, M. R. Carvalho, J. J.V. Pinheiro, A. C.M. Camargo, A. S. Moriscot, M. P. Hoffman, et al.
SIKVAV, a Laminin {alpha}1-Derived Peptide, Interacts with Integrins and Increases Protease Activity of a Human Salivary Gland Adenoid Cystic Carcinoma Cell Line through the ERK 1/2 Signaling Pathway
Am. J. Pathol., July 1, 2007; 171(1): 124 - 138.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H.-J. Lee, E.-O. Lee, Y.-H. Rhee, K. S. Ahn, G.-X. Li, C. Jiang, J. Lu, and S.-H. Kim
An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti-cancer activities by targeting angiogenesis, apoptosis and metastasis
Carcinogenesis, December 1, 2006; 27(12): 2455 - 2463.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Yasui, H. Yamamoto, C. Y. Ngan, B. Damdinsuren, Y. Sugita, H. Fukunaga, J. Gu, M. Maeda, I. Takemasa, M. Ikeda, et al.
Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor-Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization
Clin. Cancer Res., August 1, 2006; 12(15): 4720 - 4729.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Givant-Horwitz, B. Davidson, and R. Reich
Laminin-Induced Signaling in Tumor Cells: The Role of the Mr 67,000 Laminin Receptor
Cancer Res., May 15, 2004; 64(10): 3572 - 3579.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. A. Hembrough, J. F. Ruiz, B. M. Swerdlow, G. M. Swartz, H. J. Hammers, L. Zhang, S. M. Plum, M. S. Williams, D. K. Strickland, and V. S. Pribluda
Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity
Blood, May 1, 2004; 103(9): 3374 - 3380.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Scapini, M. Morini, C. Tecchio, S. Minghelli, E. Di Carlo, E. Tanghetti, A. Albini, C. Lowell, G. Berton, D. M. Noonan, et al.
CXCL1/Macrophage Inflammatory Protein-2-Induced Angiogenesis In Vivo Is Mediated by Neutrophil-Derived Vascular Endothelial Growth Factor-A
J. Immunol., April 15, 2004; 172(8): 5034 - 5040.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Russo, B. Bussolati, I. Deambrosis, F. Mariano, and G. Camussi
Platelet-Activating Factor Mediates CD40-Dependent Angiogenesis and Endothelial-Smooth Muscle Cell Interaction
J. Immunol., November 15, 2003; 171(10): 5489 - 5497.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. W. Kim, H. M. Lee, T. H. Lee, C. Kang, H. K. Kleinman, and Y. S. Gho
Extracellular Membrane Vesicles from Tumor Cells Promote Angiogenesis via Sphingomyelin
Cancer Res., November 1, 2002; 62(21): 6312 - 6317.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. A. Masso-Welch, D. Zangani, C. Ip, M. M. Vaughan, S. Shoemaker, R. A. Ramirez, and M. M. Ip
Inhibition of Angiogenesis by the Cancer Chemopreventive Agent Conjugated Linoleic Acid
Cancer Res., August 1, 2002; 62(15): 4383 - 4389.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H.-M. Ko, K. H. Seo, S.-J. Han, K. Y. Ahn, I.-H. Choi, G. Y. Koh, H.-K. Lee, M. S. Ra, and S.-Y. Im
Nuclear Factor {kappa}B Dependency of Platelet-activating Factor-induced Angiogenesis
Cancer Res., March 1, 2002; 62(6): 1809 - 1814.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Gebarowska, A. W. Stitt, T. A. Gardiner, P. Harriott, B. Greer, and J. Nelson
Synthetic Peptides Interacting with the 67-kd Laminin Receptor Can Reduce Retinal Ischemia and Inhibit Hypoxia-Induced Retinal Neovascularization
Am. J. Pathol., January 1, 2002; 160(1): 307 - 313.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Bussolati, C. Dunk, M. Grohman, C. D. Kontos, J. Mason, and A. Ahmed
Vascular Endothelial Growth Factor Receptor-1 Modulates Vascular Endothelial Growth Factor-Mediated Angiogenesis via Nitric Oxide
Am. J. Pathol., September 1, 2001; 159(3): 993 - 1008.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. L. PONCE, M. NOMIZU, and H. K. KLEINMAN
An angiogenic laminin site and its antagonist bind through the {alpha}v{beta}3 and {alpha}5{beta}1 integrins
FASEB J, June 1, 2001; 15(8): 1389 - 1397.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. B. DeRoock, M. E. Pennington, T. C. Sroka, K. S. Lam, G. T. Bowden, E. L. Bair, and A. E. Cress
Synthetic Peptides Inhibit Adhesion of Human Tumor Cells to Extracellular Matrix Proteins
Cancer Res., April 1, 2001; 61(8): 3308 - 3313.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
J. B. Wyckoff, J. E. Segall, and J. S. Condeelis
The Collection of the Motile Population of Cells from a Living Tumor
Cancer Res., October 1, 2000; 60(19): 5401 - 5404.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
C. V. Ngo, M. Gee, N. Akhtar, D. Yu, O. Volpert, R. Auerbach, and A. Thomas-Tikhonenko
An in Vivo Function for the Transforming Myc Protein: Elicitation of the Angiogenic Phenotype
Cell Growth Differ., April 1, 2000; 11(4): 201 - 210.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Montrucchio, E. Lupia, E. Battaglia, L. Del Sorbo, M. Boccellino, L. Biancone, G. Emanuelli, and G. Camussi
Platelet-Activating Factor Enhances Vascular Endothelial Growth Factor-Induced Endothelial Cell Motility and Neoangiogenesis in a Murine Matrigel Model
Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 80 - 88.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Biancone, V. Cantaluppi, M. Boccellino, L. Del Sorbo, S. Russo, A. Albini, I. Stamenkovic, and G. Camussi
Activation of CD40 Favors the Growth and Vascularization of Kaposi's Sarcoma
J. Immunol., December 1, 1999; 163(11): 6201 - 6208.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Kakolyris, A. Giatromanolaki, M. Koukourakis, I. M. Leigh, V. Georgoulias, P. Kanavaros, E. Sivridis, K. C. Gatter, and A. L. Harris
Assessment of Vascular Maturation in Non-Small Cell Lung Cancer Using a Novel Basement Membrane Component, LH39: Correlation with p53 and Angiogenic Factor Expression
Cancer Res., November 1, 1999; 59(21): 5602 - 5607.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. C. Jadeski and P. K. Lala
Nitric Oxide Synthase Inhibition by NG-Nitro-L-Arginine Methyl Ester Inhibits Tumor-Induced Angiogenesis in Mammary Tumors
Am. J. Pathol., October 1, 1999; 155(4): 1381 - 1390.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Dentelli, L. D. Sorbo, A. Rosso, A. Molinar, G. Garbarino, G. Camussi, L. Pegoraro, and M. F. Brizzi
Human IL-3 Stimulates Endothelial Cell Motility and Promotes In Vivo New Vessel Formation
J. Immunol., August 15, 1999; 163(4): 2151 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. F. Brizzi, E. Battaglia, G. Montrucchio, P. Dentelli, L. Del Sorbo, G. Garbarino, L. Pegoraro, and G. Camussi
Thrombopoietin Stimulates Endothelial Cell Motility and Neoangiogenesis by a Platelet-Activating Factor–Dependent Mechanism
Circ. Res., April 16, 1999; 84(7): 785 - 796.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. L. Ponce, M. Nomizu, M. C. Delgado, Y. Kuratomi, M. P. Hoffman, S. Powell, Y. Yamada, H. K. Kleinman, and K. M. Malinda
Identification of Endothelial Cell Binding Sites on the Laminin {gamma}1 Chain
Circ. Res., April 2, 1999; 84(6): 688 - 694.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Bagheri-Yarmand, Y. Kourbali, A. M. Rath, R. Vassy, A. Martin, J. Jozefonvicz, C. Soria, H. Lu, and M. Crepin
Carboxymethyl Benzylamide Dextran Blocks Angiogenesis of MDA-MB435 Breast Carcinoma Xenografted in Fat Pad and Its Lung Metastases in Nude Mice
Cancer Res., February 1, 1999; 59(3): 507 - 510.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. M. Malinda, M. Nomizu, M. Chung, M. Delgado, Y. Kuratomi, Y. Yamada, H. K. Kleinman, and M. L. Ponce
Identification of laminin {alpha}1 and ß1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting
FASEB J, January 1, 1999; 13(1): 53 - 62.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
G. Montrucchio, A. Sapino, B. Bussolati, G. Ghisolfi, S. Rizea-Savu, L. Silvestro, E. Lupia, and G. Camussi
Potential Angiogenic Role of Platelet-Activating Factor in Human Breast Cancer
Am. J. Pathol., November 1, 1998; 153(5): 1589 - 1596.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Silvagno, A. Follenzi, M. Arese, M. Prat, E. Giraudo, G. Gaudino, G. Camussi, P. M. Comoglio, and F. Bussolino
In Vivo Activation of met Tyrosine Kinase by Heterodimeric Hepatocyte Growth Factor Molecule Promotes Angiogenesis
Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1857 - 1865.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Nomizu, W. H. Kim, K. Yamamura, A. Utani, S.-Y. Song, A. Otaka, P. P. Roller, H. K. Kleinman, and Y. Yamada
Identification of Cell Binding Sites in the Laminin alpha1 Chain Carboxyl-terminal Globular Domain by Systematic Screening of Synthetic Peptides
J. Biol. Chem., September 1, 1995; 270(35): 20583 - 20590.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. L. Corcoran, M. C. Kibbey, H. K. Kleinman, and L. M. Wahl
Laminin SIKVAV Peptide Induction of Monocyte/Macrophage Prostaglandin E[IMAGE] and Matrix Metalloproteinases
J. Biol. Chem., May 5, 1995; 270(18): 10365 - 10368.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. A. Mesri, H. J. Federoff, and M. Brownlee
Expression of Vascular Endothelial Growth Factor From a Defective Herpes Simplex Virus Type 1 Amplicon Vector Induces Angiogenesis in Mice
Circ. Res., February 1, 1995; 76(2): 161 - 167.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
D. Grant, J. Kinsella, M. Kibbey, S LaFlamme, P. Burbelo, A. Goldstein, and H. Kleinman
Matrigel induces thymosin beta 4 gene in differentiating endothelial cells
J. Cell Sci., January 12, 1995; 108(12): 3685 - 3694.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
M. Santra, I. Eichstetter, and R. V. Iozzo
An Anti-oncogenic Role for Decorin. DOWN-REGULATION OF ErbB2 LEADS TO GROWTH SUPPRESSION AND CYTODIFFERENTIATION OF MAMMARY CARCINOMA CELLS
J. Biol. Chem., November 3, 2000; 275(45): 35153 - 35161.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.